NO308287B1 - Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse - Google Patents
Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelseInfo
- Publication number
- NO308287B1 NO308287B1 NO953367A NO953367A NO308287B1 NO 308287 B1 NO308287 B1 NO 308287B1 NO 953367 A NO953367 A NO 953367A NO 953367 A NO953367 A NO 953367A NO 308287 B1 NO308287 B1 NO 308287B1
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- amino
- substituted
- acid derivatives
- nicotinic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4430638A DE4430638A1 (de) | 1994-08-29 | 1994-08-29 | Verwendung von substituierten 4-Phenyl-6-amino-nicotinsäurederivaten als Arzneimittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO953367D0 NO953367D0 (no) | 1995-08-28 |
| NO953367L NO953367L (no) | 1996-03-01 |
| NO308287B1 true NO308287B1 (no) | 2000-08-28 |
Family
ID=6526833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953367A NO308287B1 (no) | 1994-08-29 | 1995-08-28 | Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5670525A (no) |
| EP (1) | EP0705820A1 (no) |
| JP (1) | JPH0867670A (no) |
| KR (1) | KR960007565A (no) |
| CN (1) | CN1127114A (no) |
| AU (1) | AU697552B2 (no) |
| CA (1) | CA2156961A1 (no) |
| CZ (1) | CZ219895A3 (no) |
| DE (1) | DE4430638A1 (no) |
| EE (1) | EE9500059A (no) |
| FI (1) | FI954007A (no) |
| HU (1) | HUT74618A (no) |
| IL (1) | IL115072A (no) |
| NO (1) | NO308287B1 (no) |
| NZ (1) | NZ272851A (no) |
| PL (1) | PL310145A1 (no) |
| RU (1) | RU2154635C2 (no) |
| SK (1) | SK106595A3 (no) |
| TW (1) | TW419464B (no) |
| ZA (1) | ZA957187B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU750582B2 (en) * | 1997-11-10 | 2002-07-25 | Bristol-Myers Squibb Company | Method for diagnosing Alzheimer's disease |
| DE10059418A1 (de) | 2000-11-30 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10060807A1 (de) * | 2000-12-07 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10110747A1 (de) * | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung |
| DE10115945A1 (de) | 2001-03-30 | 2002-10-02 | Bayer Ag | Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| US20050075359A1 (en) * | 2003-03-14 | 2005-04-07 | Rikako Kono | Large conductance calcium-activated K channel opener |
| WO2006091800A2 (en) * | 2005-02-24 | 2006-08-31 | Janssen Pharmaceutica N.V. | Novel pyridine derivatives as potassium ion channel openers |
| DE102006042143A1 (de) * | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
| DE102006056740A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
| DE102006056739A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
| DE102007035367A1 (de) | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
| DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
| DE102007061763A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
| DE102007061764A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Anellierte Cyanopyridine und ihre Verwendung |
| DE102008013587A1 (de) * | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
| WO2009143992A1 (de) * | 2008-05-29 | 2009-12-03 | Bayer Schering Pharma Aktiengesellschaft | 2-alkoxy-substituierte dicyanopyridine und ihre verwendung |
| DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
| DE102009006602A1 (de) * | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
| DE102010030688A1 (de) | 2010-06-30 | 2012-01-05 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dicyanopyridine und ihre Verwendung |
| US20120058983A1 (en) | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
| AU2011303597A1 (en) * | 2010-09-17 | 2013-04-11 | Purdue Pharma L.P. | Pyridine compounds and the uses thereof |
-
1994
- 1994-08-29 DE DE4430638A patent/DE4430638A1/de not_active Withdrawn
-
1995
- 1995-07-20 TW TW084107499A patent/TW419464B/zh active
- 1995-08-16 EP EP95112833A patent/EP0705820A1/de not_active Withdrawn
- 1995-08-22 US US08/517,873 patent/US5670525A/en not_active Expired - Fee Related
- 1995-08-23 AU AU30205/95A patent/AU697552B2/en not_active Ceased
- 1995-08-23 PL PL95310145A patent/PL310145A1/xx unknown
- 1995-08-24 JP JP7237915A patent/JPH0867670A/ja active Pending
- 1995-08-25 IL IL11507295A patent/IL115072A/xx not_active IP Right Cessation
- 1995-08-25 NZ NZ272851A patent/NZ272851A/en unknown
- 1995-08-25 FI FI954007A patent/FI954007A/fi unknown
- 1995-08-25 CA CA002156961A patent/CA2156961A1/en not_active Abandoned
- 1995-08-25 CN CN95116625A patent/CN1127114A/zh active Pending
- 1995-08-28 HU HU9502520A patent/HUT74618A/hu unknown
- 1995-08-28 ZA ZA957187A patent/ZA957187B/xx unknown
- 1995-08-28 EE EE9500059A patent/EE9500059A/xx unknown
- 1995-08-28 KR KR1019950026840A patent/KR960007565A/ko not_active Application Discontinuation
- 1995-08-28 RU RU95114449/04A patent/RU2154635C2/ru active
- 1995-08-28 CZ CZ952198A patent/CZ219895A3/cs unknown
- 1995-08-28 SK SK1065-95A patent/SK106595A3/sk unknown
- 1995-08-28 NO NO953367A patent/NO308287B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1127114A (zh) | 1996-07-24 |
| TW419464B (en) | 2001-01-21 |
| HUT74618A (en) | 1997-01-28 |
| IL115072A (en) | 1999-12-31 |
| CA2156961A1 (en) | 1996-03-01 |
| IL115072A0 (en) | 1995-12-08 |
| AU697552B2 (en) | 1998-10-08 |
| NZ272851A (en) | 1997-07-27 |
| AU3020595A (en) | 1996-03-14 |
| HU9502520D0 (en) | 1995-10-30 |
| ZA957187B (en) | 1996-04-17 |
| FI954007A0 (fi) | 1995-08-25 |
| CZ219895A3 (en) | 1996-03-13 |
| EE9500059A (et) | 1996-04-15 |
| EP0705820A1 (de) | 1996-04-10 |
| US5670525A (en) | 1997-09-23 |
| KR960007565A (ko) | 1996-03-22 |
| PL310145A1 (en) | 1996-03-04 |
| SK106595A3 (en) | 1997-01-08 |
| FI954007A (fi) | 1996-03-01 |
| NO953367D0 (no) | 1995-08-28 |
| DE4430638A1 (de) | 1996-03-07 |
| RU2154635C2 (ru) | 2000-08-20 |
| JPH0867670A (ja) | 1996-03-12 |
| NO953367L (no) | 1996-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308287B1 (no) | Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse | |
| NO304468B1 (no) | 6-leddede nitrogenholdige heteroaryl-oksazolidinoner, anvendelse av disse samt legemiddel inneholdende forbindelsen | |
| NO20010013D0 (no) | Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene | |
| NO304488B1 (no) | 5-leddede heteroaryloksazolidinoner, anvendelse av disse for fremstilling av legemidler samt legemiddel inneholdende forbindelsen | |
| DK0918059T3 (da) | Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater | |
| DK231687A (da) | Heterocykliske forbindelser, deres fremstilling og anvendelse, samt laegemidler indeholdende disse forbindelser | |
| NO307459B1 (no) | Piperazinderivater, samt farmasøytiske preparater inneholdende slike | |
| NO972881D0 (no) | Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling | |
| DK260386A (da) | Pyrimidinderivater samt deres anvendelse som laegemidler | |
| NO932120D0 (no) | Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
| DK85087D0 (da) | Substituerede thienoimidazol-derivater, deres fremstilling, praeparater, indeholdende disse, samt anvendelse deraf | |
| DK0562583T3 (da) | Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
| NO942910L (no) | Nye baccatin-III- og 10-desacetyl-baccatin-III-derivater, deres fremstillinger, samt farmasöytiske preparater inneholdende derivatene | |
| NO306060B1 (no) | Substituerte kanelsyreguanidider, deres anvendelse samt medikamenter inneholdende guanididene | |
| NO303120B1 (no) | Heterocykliske iminobismetylen-bisfosfonsyrederivater, farmas÷ytiske midler inneholdende dem samt deres anvendelse | |
| NO308527B1 (no) | Substituerte 2-naftoylguanidiner, deres anvendelse for fremstilling av et medikament samt legemidler og preparater inneholdende forbindelsene | |
| DK486789A (da) | Benzoxazolinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
| DK66086A (da) | Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
| DK384088D0 (da) | Substituerede benzimidazoler, deres fremstilling, praeparater indeholdende disse samt deres anvendelse som laegemidler | |
| NO892728D0 (no) | Aminoalkyl-aminokarbonyl-aminodiolaminosyre derivater somanti-hypertensive midler. | |
| DK178589D0 (da) | Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse | |
| NO308213B1 (no) | Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene | |
| DK449989D0 (da) | Quinolinderivater, deres fremstilling og laegemidler indeholdende disse derivater | |
| DK162092C (da) | Basisk substituerede 3-phenyl-quinolin-2-on-derivater, deres fremstilling og anvendelse samt laegemiddel indeholdende disse derivater | |
| NO970140D0 (no) | Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN FEBRUARY 2002 |